Janus Henderson Horizon Biotechnology Fund E2 Fonds
34,39
USD
+0,18
USD
+0,53
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Gilead Sciences Inc | US3755581036 | 4,08% |
| Amgen Inc | US0311621009 | 3,69% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 3,58% |
| Sarepta Therapeutics Inc | US8036071004 | 3,42% |
| Neurocrine Biosciences Inc | US64125C1099 | 3,37% |
| Ascendis Pharma A/S ADR | US04351P1012 | 3,20% |
| Global Blood Therapeutics Inc | US37890U1088 | 2,98% |
| Akero Therapeutics Inc | US00973Y1082 | 2,29% |
| Exelixis Inc | US30161Q1040 | 2,22% |
| ACADIA Pharmaceuticals Inc | US0042251084 | 2,16% |
| Sonstige | 69,01% |